1. Metronomic chemotherapy in advanced oral cancers;Patil;J Cancer Res Therapeut,2012
2. Head and neck cancer;Argiris;Lancet,2008
3. Laskar SG, Chaukar D, Deshpande M, et al. Phase III randomized trial of surgery followed by conventional radiotherapy (5 fr/Wk)(Arm A) vs concurrent chemoradiotherapy (Arm B) vs accelerated radiotherapy (6fr/Wk)(Arm C) in locally advanced, stage III and IV, resectable, squamous cell carcinoma of oral cavity-oral cavity adjuvant therapy (OCAT): final results (NCT00193843).
4. Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression;Ferris;Oral Oncol,2018
5. CheckMate 141: 1-year update and subgroup analysis of nivolumab as first-line therapy in patients with recurrent/metastatic head and neck cancer;Gillison;Oncol,2018